Physician financial transparency reports (Sunshine Act)
Find out how the Sunshine Act helps increase transparency about financial relationships between health care providers and pharmaceutical companies.
A medical resident’s guide to gifts from industry
Learn more from the AMA about the ethical and legal standards in this area, and how they apply to medical residents.
AMA guide for media reporting on "open payments" data release
Media should verify the accuracy of data; understand the context of financial relationships between physicians and industry when reporting on open payments data.
Medicare financial data going public: Review yours now
Physicians have until May 15 to review and dispute reports about financial interactions with manufacturers of drugs and medical devices reported under the the Open Payments program.
AMA overview clarifies CME reporting under the Sunshine Act
The AMA has provided an overview that addresses concerns about reporting requirements and participation in commercially supported, accredited and certified continuing medical education (CME) programs in 2016.
AMA statement on Sunshine Act data release
The AMA is committed to transparency and the availability of information for patients to make informed decisions about their medical care.
3 answers to know about Sunshine Act data going public
The second release of physicians’ financial data under the Physician Payments Sunshine Act, also known as the Open Payments program, was June 30. Learn the answers to three questions patients or others may ask you about your 2014 financial data.
Review financial data before it goes public in June
Physicians have 45 days to review and dispute reports regarding their financial interactions with manufacturers of drugs and medical devices reported under the Physician Payments Sunshine Act. Here’s what you need to know about the process before data is made available to the public in June.